Delivery Device Patents on GLP-1 Receptor Agonists

被引：0
|
作者：
Alhiary, Rasha [1 ]
Gabriele, Sarah [1 ]
Kesselheim, Aaron S. [1 ]
Tu, S. Sean [2 ]
Feldman, William B. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA
[2] West Virginia Univ, Coll Law, Morgantown, WV USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 331卷 / 09期
关键词：
D O I：
10.1001/jama.2024.0919
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study analyzed the US Food and Drug Administration-listed patents on glucagon-like peptide 1 (GLP-1) receptor agonists to determine their claim characteristics and the potential barriers they pose to generic entry.
引用
收藏
页码：794 / 796
页数：3
相关论文
共 50 条
  • [21] Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
    Liu, Qiyuan Keith
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [22] The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
    Silvia Tempia Valenta
    Alba Nicastri
    Federica Perazza
    Federica Marcolini
    Valentina Beghelli
    Anna Rita Atti
    Maria Letizia Petroni
    Current Treatment Options in Psychiatry, 2024, 11 (4) : 310 - 357
  • [23] GLP-1 RECEPTOR VARIANTS MARKEDLY DIFFERENTIATE GLYCAEMIC RESPONSE TO GLP-1 RECEPTOR AGONISTS: A DIRECT STUDY
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. -G
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 13 - 14
  • [24] GLP-1 receptor variants markedly differentiate glycaemic response to GLP-1 receptor agonists: a DIRECT study
    Dawed, A. Y.
    Mari, A.
    McDonald, T. J.
    Hong, M. G.
    Sharma, S.
    Robertson, N. R.
    Mahajan, A.
    Walker, M.
    Gough, S.
    Zhou, K.
    Forgie, I.
    Ruetten, H.
    Jones, A. G.
    Pearson, E. R.
    DIABETOLOGIA, 2017, 60 : S393 - S393
  • [25] Falsified versions of GLP-1 receptor agonists reported
    Reactions Weekly, 2023, 1974 (1) : 3 - 3
  • [26] Diabetic ketoacidosis with GLP-1 receptor agonists, insulin
    Reactions Weekly, 2019, 1760 (1) : 1 - 1
  • [27] GLP-1 receptor agonists and the risk of colorectal cancer
    Kakkar, Ashish Kumar
    MEDICAL HYPOTHESES, 2014, 82 (06) : 796 - 796
  • [28] GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
    Suissa, Karine
    Cromer, Sara J.
    Patorno, Elisabetta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10):
  • [29] The stimulation of GLP-1 secretion and delivery of GLP-1 agonists &ITvia&IT nanostructured lipid carriers
    Shrestha, Neha
    Bouttefeux, Oriane
    Vanvarenberg, Kevin
    Lundquist, Patrik
    Cunarro, Juan
    Tovar, Sulay
    Khodus, Georgiy
    Andersson, Ellen
    Keita, Asa V.
    Dieguez, Carlos Gonzalez
    Artursson, Per
    Preat, Veronique
    Beloqui, Ana
    NANOSCALE, 2018, 10 (02) : 603 - 613
  • [30] Appendicitis: A Hidden Danger of GLP-1 Receptor Agonists?
    Casella, Sarah
    Galli, Katelyn
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (02) : 108 - 111
12345